orphan drug incentives

Orphan drug incentives are special benefits offered by governments to encourage the development of treatments for rare diseases, which affect small patient populations. Since creating these drugs is often costly and less profitable, incentives like tax credits, grant funding, reduced regulatory fees, and extended market exclusivity are provided. These measures make it more attractive for pharmaceutical companies to invest in researching and producing medications for conditions that might otherwise be overlooked, ultimately helping patients with rare illnesses access new and effective treatments.